Literature DB >> 21212413

Significance and mechanism of lymph node metastasis in cancer progression.

Kenji Kawada1, Makoto M Taketo.   

Abstract

The effect of local therapy, such as surgical lymph node (LN) dissection and radiotherapy, on the survival of cancer patients has been debated for decades. Several lines of recent clinical evidence support that LN metastasis plays significant roles in systemic dissemination of cancer cells, although the effects of surgical LN dissection on survival was downplayed historically because of controversial data. Molecular studies of LN metastasis suggest that the microenvironment within LNs, including chemokines and lymphangiogenesis, can mediate the metastatic spread to the sentinel LNs, and beyond. It has been shown that chemokine receptor CXCR3 is involved in LN metastasis, and its inhibition may improve patient prognosis. Although it remains to be determined whether local therapy is best pursued through LN dissection or through a combination of resection with radiation, prevention of regional metastases is an important goal in the treatment of cancer patients to achieve a better survival. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212413     DOI: 10.1158/0008-5472.CAN-10-3277

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  Optical clearing based cellular-level 3D visualization of intact lymph node cortex.

Authors:  Eunjoo Song; Howon Seo; Kibaek Choe; Yoonha Hwang; Jinhyo Ahn; Soyeon Ahn; Pilhan Kim
Journal:  Biomed Opt Express       Date:  2015-09-28       Impact factor: 3.732

Review 2.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

3.  Implications for breast cancer dormancy in other areas of medicine.

Authors:  Pranela Rameshwar
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-12-05

Review 4.  [Cervical, inguinal and abdominal lymphnode dissection].

Authors:  T W Kraus; K Suna; S Berkhoff; E Jäger; U Kraus-Tiefenbacher
Journal:  Chirurg       Date:  2013-07       Impact factor: 0.955

5.  CRKII overexpression promotes the in vitro proliferation, migration and invasion potential of murine hepatocarcinoma Hca-P cells.

Authors:  Zanmei Zhou; Xiuyan Sun; Chunmei Guo; Ming-Zhong Sun; Shuqing Liu
Journal:  Oncol Lett       Date:  2019-03-27       Impact factor: 2.967

6.  Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases.

Authors:  Han-Sin Jeong; Dennis Jones; Shan Liao; Daniel A Wattson; Cheryl H Cui; Dan G Duda; Christopher G Willett; Rakesh K Jain; Timothy P Padera
Journal:  J Natl Cancer Inst       Date:  2015-06-10       Impact factor: 13.506

7.  MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.

Authors:  Melanie Rammer; Gerald Webersinke; Sophie Haitchi-Petnehazy; Eva Maier; Hubert Hackl; Pornpimol Charoentong; Theodora Malli; Maria Steinmair; Andreas L Petzer; Holger Rumpold
Journal:  Clin Exp Metastasis       Date:  2017-11-13       Impact factor: 5.150

8.  Lymph node effective vascular permeability and chemotherapy uptake.

Authors:  Eelco F J Meijer; Cedric Blatter; Ivy X Chen; Echoe Bouta; Dennis Jones; Ethel R Pereira; Keehoon Jung; Benjamin J Vakoc; James W Baish; Timothy P Padera
Journal:  Microcirculation       Date:  2017-08       Impact factor: 2.628

9.  Expression of CXCR-4 and IDO in human colorectal cancer: An immunohistochemical approach.

Authors:  Masaichi Ogawa; Michiaki Watanabe; Takuo Hasegawa; Kohei Ichihara; Kazuhiko Yoshida; Katsuhiko Yanaga
Journal:  Mol Clin Oncol       Date:  2017-04-04

10.  CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients.

Authors:  Jiali Zhang; Jing Xu; Rong-Xin Zhang; Yi Zhang; Qing-Jian Ou; Jin-Qing Li; Ze-Zhou Jiang; Xiao-Jun Wu; Yu-Jing Fang; Limin Zheng
Journal:  Oncoimmunology       Date:  2016-04-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.